RAMOT AT TEL-AVIV UNIVERSITY LTD.;TEHILA BEN-MOSHE;JACOB SCHACHTER;CCAM BIOTHERAPEUTICS LTD;TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.;SAPIR ;GAL MARKEL;RONA ORTENBERG;ILANA MANDEL
The present disclosure provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing the protein CEACAM1 and other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by comprising specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.
